AREDS2 Supplements and Geographic Atrophy Progression
Post hoc analyses of the AREDS/AREDS2 studies presented at the recent American Academy of Ophthalmology meeting examined supplementation on the risk of geographic atrophy progression.
Post hoc analyses of the AREDS/AREDS2 studies presented at the recent American Academy of Ophthalmology meeting examined supplementation on the risk of geographic atrophy progression.
MedPage Today spoke with experts during an Instagram Live 2 years ago about the growing buzz around GLP-1 receptor agonists and their role in transforming
A new CDC report indicated that the percentage of Americans with chronic pain rose considerably in recent years, and it’s not clear why. In 2023,
Vision problems could be identified using comprehensive optical assessments and machine-learning approaches among people with chronic mild traumatic brain injury (TBI), a prospective, observational, case-control
Ohio doctor Steven Werling, DO, admitted to owning improvised explosive devices, and could face up to 2 years in prison. (WHIO) Three years before William
Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Third Woman Dies Under Texas Abortion
President-elect Donald Trump has chosen health economist Jay Bhattacharya, MD, PhD, a critic of pandemic lockdowns and vaccine mandates, to lead the National Institutes of
What You Should Know: – WellRX, the parent company of preventative healthcare brands ReviveRX and Ways2Well, has acquired Bioreach, a cutting-edge bloodwork and genetics laboratory.
Marinomed Biotech AG / Key word(s): Corporate Action Marinomed Biotech AG: Binding Term Sheet for the intended issuance of a convertible bond to the European
Marinomed Biotech AG / Key word(s): Corporate Action/Capital Increase Marinomed Biotech AG: Publication of a report on the exclusion of subscription rights for a possible